KELLY BURROUGH: Open Payments
NPI 1144276890 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$663 in 37 payments from 9 companies in 2025. Trend: 2023 $438 · 2024 $1,104 · 2025 $663
Food & beverage: $663
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $173 |
| Novo Nordisk Inc | 9 | $159 |
| Abbott Laboratories | 4 | $85 |
| AstraZeneca Pharmaceuticals LP | 4 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $56 |
| Lilly USA, LLC | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| Medtronic, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $15 |
Products named: FREESTYLE LIBRE 3, ELIQUIS, Kerendia, PREVNAR 20, NURTEC ODT, AIRSUPRA, REXULTI, MOUNJARO.
Industry payments across IN — which companies pay providers there.
